HENDERSON, Nev.--(BUSINESS WIRE)--3PEA International, Inc. (OTCQB: TPNL), a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, is delighted to announce the addition of Dennis DiVenuta, JD, to its senior management team as Executive Vice President Strategy and Corporate Development. In his new role, DiVenuta joins 3PEA’s leadership team to develop, implement and execute business strategies within the healthcare and biopharmaceutical verticals that increase our client base, maximize shareholder value, and position 3PEA for future expansion.
“Dennis comes to 3PEA with an extraordinary wealth of experience and exceptional insight and knowledge of the pharmaceutical industry,” said Mark Newcomer, Chief Executive Officer, 3PEA International. “Dennis’ contributions are already proving to be invaluable as 3PEA reinforces its position as a key provider of customized payment and reimbursement solutions to the healthcare and biopharmaceutical markets.”
As an attorney with 40 years of experience in healthcare, DiVenuta has provided employers and clients with legal counsel and strategic guidance in the deployment of a multitude of largely technology based solutions.
DiVenuta has served as Corporate General Counsel at both public and private companies, as well as CEO and Executive Vice President for Business Development and Corporate Strategy at recognized industry leading companies, including Computer Horizons Corp., Ateb, Inc., MediMedia USA Inc., DrFirst as well as serving as an Executive Vice President and member of the senior management team at PSKW, LLC (now Connective Rx).
Most recently, DiVenuta was a Co-Founder and Managing Partner in Mill Pond Communications, LLC, and collaborated with the other members of the senior management team in the development of behavioral health initiatives targeting clinical trial recruitment and educational content. These projects were designed to increase patient comprehension of trial protocols and the underlying diseases related to such trials. He was primarily responsible for the creation and management of strategic partnerships with organizations such as Stand Up to Cancer as well as a variety of other stakeholders in the research and development sector of the pharmaceutical industry.
DiVenuta holds a BA in American History from Montclair State College and a Juris Doctor Degree in Law from St. John’s University in New York.
About 3PEA International
3PEA International (OTCQB:TPNL) is an experienced and trusted prepaid debit card payment solutions provider as well as an integrated payment processor that has managed millions of prepaid debit cards in its portfolio. Through its PaySign brand, 3PEA conceptualizes, develops and manages payment solutions, prepaid card programs, and customized payment services. 3PEA’s corporate incentive prepaid cards are changing the way corporations reward, motivate, and engage their current and potential customers, employees, and agents. 3PEA’s customizable prepaid solutions offer significant cost savings while improving brand recognition and customer loyalty. 3PEA’s customers include healthcare companies, major pharmaceutical companies, large multinationals, prestigious universities, and social media companies. PaySign is a registered trademark of 3PEA Technologies, Inc. in the United States and other countries. For more information visit us at www.3pea.com or follow us on LinkedIn, Twitter and Facebook.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There is no assurance that such statements will prove to be accurate, and actual results and future events could differ materially. 3PEA undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.